Polyradiculoneuropathy Chronic Inflammatory Demyelinating

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-02
Clinical Trial Update: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]
Phase 3 extension study evaluating maintenance subcutaneous immunoglobulin (IgPro20) in CIDP has been completed with posted results.